Electroconvulsive therapy in the presence of brain tumor. Case reports and an evaluation of risk.

Published

Journal Article

The clinical basis for the long established contraindication of electroconvulsive therapy (ECT) in the presence of brain tumor is reviewed, as is the recent literature that has questioned the absolute nature of that contraindication. A need for a specific estimate of risk is noted. Seven retrospective case reports are added to the 28 cases reported in the literature. The clinical case report data are then pooled and evaluated by outcome. Results indicate a 74 per cent overall morbidity, including a 28 per cent 1-month mortality rate for patients with brain tumors who receive ECT. Twenty-one per cent of the patients had a positive behavioral response to ECT without complication.

Full Text

Duke Authors

Cited Authors

  • Maltbie, AA; Wingfield, MS; Volow, MR; Weiner, RD; Sullivan, JL; Cavenar, JO

Published Date

  • July 1, 1980

Published In

Volume / Issue

  • 168 / 7

Start / End Page

  • 400 - 405

PubMed ID

  • 7400788

Pubmed Central ID

  • 7400788

International Standard Serial Number (ISSN)

  • 0022-3018

Language

  • eng

Conference Location

  • United States